SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Extremities Market Recap.
The US Extremities Market experienced a slight dip in Q118, with sequential growth down from +8.4% to +6.9% that extended into all categories. While Q118 was relatively quiet, FDA clearances, new competitive products and new players in Shoulder, Ankles and Fixation should heat up the segment in 2018.
Among the many topics covered in the Q118 Extremities Market Recap are: